Finance

Lists
CGTX:NASDAQ
Cognition Therapeutics Inc
US$ ०.९६
+०.५९%
(+०.००५६) 1D
US$ ०.९७
+१.०४% (+०.०१०)
Pre-market
Closed: सेप्टेम्बर ३०, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGTX...
Open
US$ ०.९८
High
US$ ०.९८
Low
US$ ०.९६
Mkt. cap
९.१७ करोड
Avg. vol.
४.०० लाख
Volume
९४१.००
52-wk high
US$ २.०५
52-wk low
US$ ०.५५
EPS
-US$ ०.२०
Beta
१.७९
Shares outstanding
९.५१ करोड
No. of employees
१४
Open
US$ ०.९८
High
US$ ०.९८
Low
US$ ०.९६
Mkt. cap
९.१७ करोड
Avg. vol.
४.०० लाख
Volume
९४१.००
52-wk high
US$ २.०५
52-wk low
US$ ०.५५
EPS
-US$ ०.२०
Beta
१.७९
Shares outstanding
९.५१ करोड
No. of employees
१४
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
२ घण्टा पहिले
S&P 500 alarm bells are starting to go off
www.marketscreener.com
www.marketscreener.com
·
२८ मिनेट पहिले
Mizuho Adjusts Price Target on Dow to $32 From $35, Maintains Neutral Rating
TradingView
TradingView
·
१ घण्टा पहिले
Accelevation, Data Center Infrastructure Platform, Files for Nasdaq $540M IPO
Bloomberg.com
Bloomberg.com
·
३ घण्टा पहिले
Asian Stocks Eye Rough Start After US Reversal: Markets Wrap
About Cognition Therapeutics Inc
CEO-
Employees१४
Founded२००७ जनवरी १
Headquarters-
Sector-
Websitecogrx.com
Analyst ratings
Based on 1 analyst giving stock ratings to CGTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CGTX in the last 3 months
Highest
Current US$ ०.९६
US$ ३.०० (+२१२.५०%)
Average
US$ ३.०० (+२१२.५०%)
Lowest
US$ ३.०० (+२१२.५०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Maintained
US$ ३.००
+२१२.५%
09/21/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
US$ ४.००
+३१६.७%
05/08/2026
William Wood
B. Riley Securities
Buy
Maintained
US$ ३.००
+२१२.५%
11/21/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
३७.७३ लाख
१.११ करोड
६१.२० लाख
५०.९७ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२६.०२ लाख
२५.२४ लाख
२६.९७ लाख
२६.४१ लाख
Operating expense
६३.७५ लाख
१.३७ करोड
८८.१७ लाख
७७.३८ लाख
Total operating expenses
६३.७५ लाख
१.३७ करोड
८८.१७ लाख
७७.३८ लाख
Operating income
-६३.७५ लाख
-१.३७ करोड
-८८.१७ लाख
-७७.३८ लाख
Other non operating income
१४.४५ लाख
१.०३ करोड
४२.५२ लाख
३८.०९ लाख
EBT including unusual items
-४९.३० लाख
-३३.४३ लाख
-४५.७० लाख
-३९.३२ लाख
EBT excluding unusual items
-४९.३० लाख
-३३.४३ लाख
-४५.७० लाख
-३९.३२ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-४९.३० लाख
-३३.४३ लाख
-४५.७० लाख
-३९.३२ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.०६
-०.०२
-०.०५
-०.०४
Interest and investment income
-
-
-
-
Interest expense
-
-५.०० हजार
-५.०० हजार
-३.०० हजार
Net interest expenses
-
-५.०० हजार
-५.०० हजार
-३.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-६३.६० लाख
-१.३७ करोड
-८८.०६ लाख
-७७.२८ लाख
Gain or loss from assets sale
-
४१.०० हजार
५.०० हजार
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू